The 48th Annual Meeting of the Japanese Society for Immunology Dates: 11–13 December, 2019 Venue: Act City Hamamatsu President: Tomohiro Kurosaki (Osaka University)

Best Presentation Award Winner 2019

JSI gives an award to the superior presenters in the workshop and poster session of the JSI Annual Meeting.
One / Two awardees are selected in an each category by workshop coordinators and chairpersons.
This award is supported by BioLegend and Tomy Digital Biology.

1. Hematopoiesis and Immune Environment

Program NoNameTitle
1-H-W6-19-O/P Yusuke Amemiya (Tokyo University of Science) Accumulation of leukemic cells to the spleen is regulated by a transcription factor Tlx1 expressed in perifollicular mesenchymal cells

2. B cells

Program NoNameTitle
2-F-W10-19-O/P Sarah G Leach (Osaka University) Requirement for memory B cell activation in protection from heterologous influenza virus reinfection

3. T cells

Program NoNameTitle
1-C-W1-16-O/P Kosuke Miyauchi (RIKEN) The influenza virus replication derived broad protective antibody response
2-C-W8-6-O/P Tomoyoshi Yamano (Kanazawa University) A role of extracelluar vesicles in T cell development

4. Innate lymphocytes

Program NoNameTitle
3-E-W19-5-O/P Natsuko Otaki (Keio University) The role of group 2 innate lymphoid cells(ILC2) in pulmonary fibrosis

5. Dendritic cells, macrophages, granulocytes

Program NoNameTitle
3-F-W20-3-O/P Hisashi Ueta (Dokkyo Medical University) Novel DC targeting by allogenic T-cells for multifocal prophylactic antibody production
3-F-W21-6-O/P Etsuko Toda (Nippon Medical School) A chemokine signal amplifier FROUNT regulates tumor cell-mediated macrophage activation and migration to tumor sites

6. Allergy

Program NoNameTitle
3-D-W17-12-O/P Kazumasa Kanemaru (University of Tsukuba) Clec10a regulates mite-induced dermatitis
3-D-W18-38-O/P Hiroki Kabata (Keio University) Targeted deletion of TSLP receptor reveals cellular mechanisms underlying acute versus chronic type 2 inflammation

7. Cytokines and chemokines

Program NoNameTitle
1-D-W2-15-O/P Yuki Hikichi (RIKEN) The mechanism for regulation of type 2 cytokine production from ILC2 by Tristetraprolin.

8. Tolerance and Immune suppression

Program NoNameTitle
1-E-W3-3-O/P Kazuki Sato (University of Tsukuba) DNAM-1 suppresses Foxp3 stability of regulatory T cells in a TIGIT dependent manner

9. Virus infectionBacterial / mycofungal / parasite infection

Program NoNameTitle
3-C-W15-5-O/P Kana Ishikawa (Kumamoto University) Circulating extracellular vesicle miR-451a, but not human papilloma virus vaccine, plays a crucial role in an autoimmune disorder
3-C-W16-3-O/P Ariel Pradipta (Osaka University) Critical role of Irgm2 in host defense mechanism against Toxoplasma gondii

10. Innate immunity

Program NoNameTitle
1-G-W5-19-O/P Takashi Mino (Kyoto University) Unwinding of stem-loops by UPF1 licenses Regnase-1 to degrade inflammatory mRNAs
2-E-W9-6-O/P Kohei Tsujimoto (Osaka University) Lamtor1/p18 is required for activation of inflammasome

11. Mucosal-Skin Immunity

Program NoNameTitle
2-G-W11-15-O/P Takuro Nii (Osaka University) Intestinal Prevotella copri isolated from rheumatoid arthritis patients exacerbates murine models of arthritis
3-G-W22-1-O/P Motoyoshi Nagai (Keio University) The impact of fasting on immune cell dynamics and mucosal immune response
3-G-W23-13-O/P Sonoko Takahashi (RIKEN) Homeostatic pruning and activity of epidermal nerves are dysregulated in barrier-impaired skin during chronic itch development

12. Autoimmune diseases

Program NoNameTitle
2-B-W7-1-O/P Natsuko Yamakawa (National Institutes of Biomedical Innovation, Health and Nutrition) Human TLR7 deficiency results in autoimmune conditions
3-B-W13-21-O/P Hachiro Konaka (Osaka University) Inflammasome drives release of mitochondrial DNA enclosed in extracellular membrane vesicles and propagation of inflammation in Bechet disease
3-B-W14-2-O/P Nobuhiko Takahashi (Hokkaido University) Survival of peripherally derived monocytes in the CNS is crucial for EAE relapse

13. Tumor immunity

Program NoNameTitle
2-H-W12-1-O/P Shohei Koyama (Osaka University) Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors
3-H-W24-7-O/P Yuta Nakazawa (University of Tsukuba) An inhibitory immunoreceptor CD300a suppresses tumor infiltrating Treg cells and tumor development through binding to phosphatidylserine on tumor-derived exosomes
3-H-W25-17-O/P Hiroyasu Aoki (Tokyo University of Science) Antibody-mediated transient depletion of CD4+ cells enhances the remodeling of the T-cell receptor repertoire and promotes anti-tumor immune responses in cancer patients

14. Human Immunology (Immunointervention)

Program NoNameTitle
1-F-W4-6-O/P Ari Itoh-Nakadai (RIKEN) Creation of HLA class I and class II Tg NOD/SCID/Il2rgKO (NSG) mice for studying interaction between human immunity and leukemia

page top